Compounds
US11578039B2 · kind B2 · utility
8Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2022 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | May 6, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I, or pharmaceutically acceptable salts thereof, as well as compositions comprising such compounds. These compounds and compositions have uses in the treatment of psychiatric or neurological disorders. Compounds of formula I comprise at least one deuterium atom at the α-position and consequently have improved oral bioavailability relative to α-diprotic analogues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.